ICU Medical
ICU Medical, Inc., a leading player in the medical device industry, is headquartered in San Clemente, California, with significant operations across North America, Europe, and Asia. Founded in 1984, the company has established itself as a pioneer in innovative infusion therapy and critical care solutions. ICU Medical is renowned for its advanced infusion systems, including smart pumps and IV solutions, which enhance patient safety and streamline clinical workflows. The company’s commitment to quality and innovation has positioned it as a trusted partner in healthcare, with notable achievements such as the integration of its technologies into various hospital systems worldwide. With a strong focus on improving patient outcomes, ICU Medical continues to set industry standards, making it a vital contributor to the evolving landscape of medical technology.
DitchCarbon Score
How does ICU Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ICU Medical's score of 32 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ICU Medical's reported carbon emissions
In 2023, ICU Medical reported total carbon emissions of approximately 42,110 tonnes CO2e, broken down into Scope 1 emissions of 420 tonnes CO2e, Scope 2 emissions of 710 tonnes CO2e, and significant Scope 3 emissions of about 41,980 tonnes CO2e. The Scope 3 emissions included major contributions from business travel (20,720 tonnes CO2e) and downstream transportation and distribution (20,780 tonnes CO2e). ICU Medical has set ambitious climate commitments, aiming for Net Zero emissions by 2050 within the United Kingdom. The company projects a 25% reduction in Scope 3 emissions by 2030, using 2022 as the baseline year. These initiatives reflect a proactive approach to addressing climate change and reducing their overall carbon footprint across all scopes of emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2023 | |
|---|---|
| Scope 1 | 420 |
| Scope 2 | 710 |
| Scope 3 | 41,980 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ICU Medical is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
